Heart Transplant Clinical Trials

Clinical trials related to Heart Transplant Procedure

AlloSure Test Characteristics in Immunologically Quiescent and Immunologically Active Heart Transplant Recipients: Does Maximal Cardiopulmonary Stress Testing Prior to Assay Preserve Test Specificity While Enhancing Sensitivity?

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Observational
SUMMARY

1. Cell-free DNA does not vary significantly as a function of the activity of immunologically quiescent cardiac transplant recipients, despite the metabolic demands of the transplanted organ. (The implication of the null result would be that no restrictions to patient activity, nor modification of cardiac rehabilitation prescription, would be necessary to maintain proper test characteristics of AlloSure testing). 2. In immunologically active cardiac transplant allografts, exercise prior to assay of donor-derived cell-free DNA can be used to increase the sensitivity of the AlloSure test. (The implication of this would be that the optimal time-frame for drawing an Allosure may actually be post-exercise, and that window will be characterized).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Post-orthotopic heart transplant patients

Locations
United States
Texas
Baylor Scott & White health research institute
RECRUITING
Dallas
Contact Information
Primary
Aayla Jamil, MBBS MPH
Aayla.Jamil@bswhealth.org
214-820-1675
Time Frame
Start Date: 2020-05-21
Estimated Completion Date: 2027-12
Participants
Target number of participants: 27
Treatments
transplant recipients <1year without AMR
20 recent transplant recipients (\<1 year) without antibody-mediated rejection (AMR);
3 months post-heart transplant with AMR
• 7 transplant recipients, at least 3 months post-transplant, with antibody-mediated rejection
Related Therapeutic Areas
Sponsors
Leads: Baylor Research Institute

This content was sourced from clinicaltrials.gov